Core Viewpoint - A class action securities lawsuit has been filed against Rentokil Initial plc, alleging securities fraud that negatively impacted investors between December 1, 2023, and September 10, 2024 [1][2]. Group 1: Allegations of the Lawsuit - The lawsuit claims that Rentokil faced significant disruptions during the early integration of Terminix, leading to execution challenges [2]. - It is alleged that Rentokil and Terminix remained separate entities and that the failure to integrate negatively affected the company's business, particularly organic revenue growth in North America [2]. - Positive statements made by the defendants regarding the company's operations and prospects are claimed to be materially false and misleading due to the aforementioned issues [2]. Group 2: Next Steps for Affected Investors - Investors who suffered losses during the specified timeframe have until January 27, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as a leading securities litigation firm in the United States [4].

Core Viewpoint - Girard Sharp, LLP is investigating alleged securities fraud claims on behalf of Rentokil shareholders who experienced substantial losses between December 1, 2023, and September 10, 2024 [1][2] Group 1: Company Overview - Rentokil is a UK-based pest control company that acquired Memphis-based Terminix in 2022 [2] - On September 11, 2024, Rentokil disclosed a decline in trading performance, attributing it to "execution problems" rather than a broader market trend [2] Group 2: Financial Impact - Following the disclosure of declining trading performance, Rentokil's share price fell by 21% [2] Group 3: Legal Action - Girard Sharp is representing investors, consumers, and institutions in class actions and complex litigation, including a recent $36.5 million securities settlement against Maxar Technologies [4]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Rentokil Initial plc regarding a class action lawsuit due to alleged misleading statements and execution challenges related to the integration of Terminix [1][2]. Group 1: Allegations and Issues - The complaint alleges that during the class period from December 1, 2023, to September 10, 2024, Rentokil made materially false and misleading statements about its business operations [2]. - Specific allegations include disruptions in the early pilots of the Terminix integration, ongoing execution challenges, and the failure to integrate Terminix, which negatively impacted organic revenue growth in North America [2]. - The lawsuit claims that Rentokil's positive statements about its business lacked a reasonable basis and were misleading [2]. Group 2: Class Action Details - Shareholders who purchased shares of Rentokil during the specified class period are encouraged to register for the class action, with a deadline for lead plaintiff applications set for January 27, 2025 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. - Participation in the case incurs no cost or obligation for the shareholders [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and illegal business practices [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Points - ClaimsFiler reminds investors that the deadline to file lead plaintiff applications in a securities class action lawsuit against Rentokil Initial plc is January 27, 2025, for those who purchased the Company's American Depositary Shares between December 1, 2023, and September 10, 2024 [1] - The lawsuit alleges that Rentokil and certain executives failed to disclose material information during the Class Period, violating federal securities laws [3] - On September 11, 2024, Rentokil announced a significant reduction in expected organic revenue growth in North America to only 1% for the second half of 2024, leading to a more than 21% drop in the price of its ADSs [4] Company Information - The case is titled Laborers Local 235 Pension Fund v. Rentokil Initial plc, et al., No. 24-cv-2932 [5] - ClaimsFiler serves as a resource for retail investors to recover funds from securities class action settlements, providing various services including registration for information on securities cases and free case evaluations [6]

LOS ANGELES, Dec. 4, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rentokil Initial plc ("Rentokil" or "the Company") (NYSE: RTO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 1, 2023 and September 10, 2024, inclusive (the "Class Period" ...

NEW ORLEANS, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 27, 2025 to file lead plaintiff applications in a securities class action lawsuit against Rentokil Initial plc (the “Company”) (NYSE: RTO), if they purchased the Company’s American Depositary Shares (“ADSs”) between December 1, 2023 and September 10, 2024, inclusive (the “Class Period”). This action is pending ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Rentokil Initial plc due to alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by January 27, 2025 [2][4]. Company Overview - Rentokil Initial plc is a publicly traded company on the NYSE under the ticker RTO [2]. - The company has faced significant challenges in integrating Terminix, which has negatively impacted its business operations and organic revenue growth in North America [4][7]. Allegations and Financial Impact - The complaint alleges that Rentokil made false or misleading statements regarding its integration of Terminix, failing to disclose execution challenges and disruptions [4]. - Following the release of disappointing financial results for Q1 2024, Rentokil's stock price fell over 9%, from $28.25 to $25.61 per ADS [5][6]. - On September 11, 2024, Rentokil announced a revised expectation of only 1% organic revenue growth for the second half of 2024, leading to a further decline in stock price of over 21%, from $31.60 to $24.95 per ADS [7]. Legal Proceedings - Investors who suffered losses exceeding $75,000 between December 1, 2023, and September 10, 2024, are encouraged to contact Faruqi & Faruqi to discuss their legal options [1]. - The role of lead plaintiff in the class action lawsuit is open to any member of the putative class, with the ability to direct and oversee the litigation [8]. Call for Information - Faruqi & Faruqi is seeking information from whistleblowers, former employees, and shareholders regarding Rentokil's conduct [9].

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Rentokil Initial Plc (“Rentokil” or the “Company”) (NYSE: RTO) in the United States District Court for the Western District of Tennessee on behalf of all persons and entities who purchased or otherwise acquired Rentokil securities between December 1, 2023 and September 10, 2024, both dates inclusive (the “Class Period”). In ...

NEW YORK, Dec. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Shares (“ADS”) of Rentokil Initial plc (NYSE: RTO) between December 1, 2023 and September 10, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 27, 2025. SO WHAT: If you purchased Rento ...

NEW YORK, Nov. 29, 2024 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Shares ("ADS") of Rentokil Initial plc (NYSE: RTO) between December 1, 2023 and September 10, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 27, 2025.So what: If you purchased Rentokil Ame ...